Dr. Mark Grinstaff<\/strong> is a professor of Biomedical Engineering (BME), Chemistry (CHEM), Materials Science and Engineering (MSE), and Medicine (MED) at Boston University. He is also <\/span>the Director of the NIH\u00a0T32 Program in Translational Research in Biomaterials<\/a> (TRB)\u00a0and the\u00a0Nanotechnology Innovation Center<\/a> (BUnano)\u00a0at\u00a0Boston University.<\/p>\n The Grinstaff Group<\/a> studies polymers, biomaterials, nanomaterials, wound repair, and tissue engineering. The lab pursues highly interdisciplinary research in the areas of biological and macromolecular chemistry to elucidate fundamental chemistry and engineering principles and use that insight to direct the lab’s creative and scientific efforts. The Grinstaff Group <\/span>designs, synthesizes, and characterizes novel dendrimers, termed \u201cbiodendrimers,\u201d for tissue engineering and biotechnological applications. They evaluate these novel biomaterials for the repair of corneal lacerations, for the delivery of anti-cancer drugs, for the delivery of DNA, and as temporary biodegradable scaffolds for cartilage repair. The group <\/span>creates novel polymeric coatings termed \u201cinterfacial biomaterials\u201d that control biology on plastic, metal, and ceramic surfaces. And they <\/span>design electrochemical-based sensors\/devices using conductive polymer nanostructures and specific DNA structural motifs.<\/span><\/p>\n Previous REU\/RET Projects Include:<\/strong><\/p>\n\n